COR1167 (Recruiting)
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 3-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1167 in Healthy Subjects and Subjects with Chronic Heart Failure
- Medicine
- COR-1167
- Population
- Heart failure
- Phase
- I
- Starting year
- 2023